We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Valeant Sells Female Libido Drug Biz Amid Shareholder Suit

Law360, Wilmington (November 6, 2017, 4:39 PM EST) -- Its passion for a female libido drug venture cooled by a shareholder lawsuit, Valeant Pharmaceuticals announced a breakup with Sprout Pharmaceuticals on Monday, handing the business off to a buyer affiliated...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.